Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli

Journal of Medical Microbiology

Volumn 53, Issue 5, 2004, Pages 439-443

  Trott, Darren J ^a   Filippich, Lucio J ^a   Bensink, John C ^a   Downs, Mary T ^a   McKenzie, Suzanne E ^a   Townsend, Kirsty M ^a   Moss, Susan M ^a   Chin, James J C ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NSW DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXACIN; ENROFLOXACIN; GENTAMICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL FLORA; BACTERIAL INFECTION; COLIFORM BACTERIUM; CONTROLLED STUDY; DOG; DRUG EFFICACY; ESCHERICHIA COLI; FECES; FECES MICROFLORA; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; COLONY COUNT, MICROBIAL; DIGESTIVE SYSTEM; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FLUOROQUINOLONES; MALE; MICROBIAL SENSITIVITY TESTS; MODELS, ANIMAL; QUINOLONES;

EID: 2342471286     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05473-0     Document Type: Article

References (20)

1. Bloch, N., Sidjabat-Tambunan, H., Tratt, T., Bensink, J., Lea, K. & Frost, A. J. (1996). The enumeration of coliforms and E. coli on naturally contaminated beef: a comparison of the Petrifilm™ method with the Australian standard. Meat Sci 43, 187-193.
2. Boerlin, P., Eugster, S., Gaschen, F., Straub, R. & Schawaldar, P. (2001). Transmission of opportunistic pathogens in a veterinary teaching hospital. Vet Microbiol 82, 347-359.
3. Cooke, C. L., Singer, R. S., Jang, S. S. & Hirsh, D. C. (2002). Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. J Am Vet Med Assoc 220, 190-192.
4. Edlund, C. & Nord, C. E. (1999). Effect of quinolones on intestinal ecology. Drugs 58 (Suppl. 2), 65-70.
5. Edlund, C. & Nord, C. E. (2000). Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J Antimicrob Chemother 46 (Suppl. 1), 41-48.
6. Féria, C., Ferreira, E., Correia, J. D., Goncalves, J. & Canica, M. (2002). Patterns and mechanisms of resistance to β-lactams and β-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. J Antimicrob Chemother 49, 77-85.
7. Garau, J., Xercavins, M., Rodríguez-Carballeíra, M., Gómez-Vera, J. R., Coll, I., Vidal, D., Llovet, T. & Ruíz-Bremón, A. (1999). Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 43, 2736-2741.
8. Hanson, N. D., Moland, E. S., Hossain, A., Neville, S. A., Gosbell, I. B. & Thomson, K. S. (2002). Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases. J Antimicrob Chemother 49, 1011-1014.
9. Johnson, J. R., Stell, A. L. & Delavari, P. (2001). Canine feces as a reservoir of extraintestinal pathogenic Escherichia coli. Infect Immun 69, 1306-1314.
10. NCCLS (1998). Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Proposed standard. NCCLS document M31-A. Villanova, PA: National Committee for Clinical Laboratory Standards.
11. Prescott, J. F., Hanna, W. J. B., Reld-Smith, R. & Drost, K. (2002). Antimicrobial drug use and resistance in dogs. Can Vet J 43, 107-116.
12. Reeves, D. S. (1986). The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials. J Antimicrob Chemother 18 (Suppl. D), 89-102.
13. Richard, P., Delangle, M. H., Raffi, F., Espaze, E. & Richet, H. (2001). Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora. Clin Infect Dis 32, 162-166.
14. Rupp, M. E. & Fey, P. D. (2003). Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 63, 353-365.
15. Sakata, K., Fujita, K. & Yoshioka, H. (1986). The effect of antimicrobial agents on fecal flora of children. Antimicrob Agents Chemother 29, 225-229.
16. Sanchez, S., McCrackin Stevenson, M. A., Hudson, C. R., Maier, M., Buffington, T., Dam, O. & Maurer, J. J. (2002). Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. J Clin Microbiol 40, 3586-3595.
17. Teshager, T., Domínguez, L., Morenzo, M. A., Saénz, Y., Torres, C. & Cardenosa, S. (2000). Isolation of an SHV-12 β-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections. Antimicrob Agents Chemother 44, 3483-3484.
18. Townsend, K., Stokes, H., Moss, S. & Trott, D. (2002). Multi-drug resistant Escherichia coli in a veterinary teaching hospital: mechanisms of resistance. In Abstracts of the 102nd General Meeting of the American Society for Microbiology, p. A-2613. Washington, DC: American Society for Microbiology.
19. van der Waaij, D. & Nord, C. E. (2000). Development and persistence of multi-resistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem. Int J Antimicrob Agents 16, 191-197.
20. Warren, A., Townsend, K., King, T., Moss, S., O'Boyle, D., Yates, R. & Trott, D. J. (2001). Multi-drug resistant Escherichia coli with extended-spectrum β-lactamase activity and fluoroquinolone resistance isolated from clinical infections in dogs. Aust Vet J 79, 621-623.